Mollick J A, Miller G G, Musser J M, Cook R G, Grossman D, Rich R R
Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas 77030.
J Clin Invest. 1993 Aug;92(2):710-9. doi: 10.1172/JCI116641.
Streptococcus pyogenes (group A Streptococcus) has re-emerged in recent years as a cause of severe human disease. Because extracellular products are involved in streptococcal pathogenesis, we explored the possibility that a disease isolate expresses an uncharacterized superantigen. We screened culture supernatants for superantigen activity with a major histocompatibility complex class II-dependent T cell proliferation assay. Initial fractionation with red dye A chromatography indicated production of a class II-dependent T cell mitogen by a toxic shock-like syndrome (TSLS) strain. The amino terminus of the purified streptococcal superantigen was more homologous to the amino termini of staphylococcal enterotoxins B, C1, and C3 (SEB, SEC1, and SEC3), than to those of pyrogenic exotoxins A, B, C or other streptococcal toxins. The molecule, designated SSA, had the same pattern of class II isotype usage as SEB in T cell proliferation assays. However, it differed in its pattern of human T cell activation, as measured by quantitative polymerase chain reaction with V beta-specific primers. SSA activated human T cells that express V beta 1, 3, 15 with a minor increase of V beta 5.2-bearing cells, whereas SEB activated V beta 3, 12, 15, and 17-bearing T cells. Immunoblot analysis of 75 disease isolates from several localities detected SSA production only in group A streptococci, and found that SSA is apparently confined to only three clonal lineages as defined by multilocus enzyme electrophoresis typing. Isolates of one of these lineages, (electrophoretic type 2) are strongly associated with TSLS. The data identify SSA as a novel streptococcal superantigen that appears to be more related structurally to staphylococcal enterotoxins than to streptococcal exotoxins. Because abundant SSA production is apparently confined to only three streptococcal clonal lineages, the data also suggest that the SSA gene has only recently been acquired by S. pyogenes.
近年来,酿脓链球菌(A 组链球菌)再度成为引发人类严重疾病的病原体。由于细胞外产物参与了链球菌的致病过程,我们探究了疾病分离株表达一种未被鉴定的超抗原的可能性。我们采用主要组织相容性复合体 II 类依赖性 T 细胞增殖试验,对培养上清液进行超抗原活性筛选。用红色染料 A 层析法初步分级分离表明,一株中毒性休克样综合征(TSLS)菌株产生了一种 II 类依赖性 T 细胞有丝分裂原。纯化后的链球菌超抗原的氨基末端与葡萄球菌肠毒素 B、C1 和 C3(SEB、SEC1 和 SEC3)的氨基末端相比,与致热外毒素 A、B、C 或其他链球菌毒素的氨基末端的同源性更高。这种分子被命名为 SSA,在 T 细胞增殖试验中,其 II 类同种型使用模式与 SEB 相同。然而,通过使用 Vβ特异性引物的定量聚合酶链反应检测,它在人类 T 细胞激活模式上有所不同。SSA 激活表达 Vβ1、3、15 的人类 T 细胞,同时表达 Vβ5.2 的细胞略有增加,而 SEB 激活表达表达 Vβ3、12、15 和 17 的 T 细胞。对来自几个地区的 75 株疾病分离株进行免疫印迹分析,结果显示仅在 A 组链球菌中检测到 SSA 的产生,并且发现 SSA 显然仅局限于多位点酶电泳分型所定义的三个克隆谱系。这些谱系之一(电泳型 2)的分离株与 TSLS 密切相关。这些数据表明 SSA 是一种新型的链球菌超抗原,其在结构上似乎与葡萄球菌肠毒素的关系比与链球菌外毒素的关系更为密切。由于大量 SSA 的产生显然仅局限于三个链球菌克隆谱系,这些数据还表明化脓性链球菌最近才获得 SSA 基因。